artículo académico

• A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America.  The Pediatric Infectious Disease Journal.  36:e272-e282. 2017
• Implementation of diverse non‑centrosymmetric layer concepts for tuning the interface activity of a magnesium alloy.  Applied Adhesion Science.  4:6. 2016
• Etiology and Antimicrobial Susceptibility of Middle Ear Fluid Pathogens in Costa Rican Children With Otitis Media Before and After the Introduction of the 7-Valent Pneumococcal Conjugate Vaccine in the National Immunization Program.  Medicine.  94:e320. 2015
• In vitro Activity of Cefditoren against Middle Ear Fluid Isolates from Costa Rican Children with Otitis Media.  Chemotherapy.  60:211-218. 2015
• Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants.  Vaccine.  32:965-972. 2014
• Enfermedad meningocócica: epidemiología, diagnóstico y vacunación./Meningococcal disease: epidemiology, diagnosis and vaccination.  Acta Médica Costarricense.  55:8-17. 2013
• Streptococcus pneumoniae Upper Respiratory Carriage in Costa Rican Children with Otitis Media before the Introduction of the Heptavalent Conjugated Vaccine in the National Immunization Program.  World Journal of Vaccines.  03:39-45. 2013
• Bacteriology of Community-Acquired Invasive Disease Found in a Multicountry Prospective, Population-Based, Epidemiological Surveillance for Pneumococcus in Children in Latin America..  The Pediatric Infectious Disease Journal.  31:1312-1314. 2012
• Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica.  Vaccine.  30:2342-2348. 2012
• Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population.  Vaccine.  30:3857-3861. 2012
• Vigilancia epidemiológica prospectiva de la enfermedad neumocócica invasora y de la neumonía en niños de San José, Costa Rica.  Acta Médica Costarricense.  54:252-261. 2012
• Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age.  Human vaccines.  7:58-66. 2011
• Prevenar experience.  Vaccine.  29:C26-C34. 2011
• Streptococcus pneumoniae serotype 6C in Costa Rican children with otitis media before introduction of the 7-valent pneumococcal conjugated vaccine into the national immunization program.  Journal of Pediatric Infectious Diseases.  6:243-246. 2011
• Avances en el desarrollo de las vacunas neumocócicas conjugadas.  Acta Médica Costarricense.  52:137-147. 2010
• Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.  Vaccine.  28:3171-3179. 2010
• Streptococcus pneumoniae Serotype 3 among Costa Rican Children with Otitis Media: Clinical, epidemiological characteristics and antimicrobial resistance patterns.  BMC Pediatrics.  9:1-6. 2009